PFIZER INC — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-28

Reporting Person: GOETTLER MICHAEL (Group President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-28	Common Stock	M	22852.0000	$27.3700	Acquired	53036.0000	Direct
2020-02-28	Common Stock	F	4419.0000	$33.4200	Disposed	48617.0000	Direct
2020-02-28	Common Stock	F	11805.0000	$36.4500	Disposed	36812.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-28	Stock Appreciation Rights	$27.3700	M	22852.0000	Disposed	2020-02-28	Common Stock (22852.0000)	Direct

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.